Concepedia

Publication | Open Access

Randomized Trial of Osilodrostat for the Treatment of Cushing Disease

DOIFull Paper Access

96

Citations

9

References

2022

Year

Mônica R. Gadelha, Marie Bex, Richard A. Feelders, Anthony P. Heaney, Richard J. Auchus, Aleksandra Gilis‐Januszewska, Przemysław Witek, Zhanna Belaya, Yerong Yu, Zhihong Liao,
The Journal of Clinical Endocrinology & Metabolism

Abstract

Osilodrostat rapidly normalized mUFC excretion in most patients with Cushing disease and maintained this effect throughout the study. The safety profile was favorable.

References

YearCitations

Page 1